Clinical Trials

Our clinic trial news comes directly from the U.S. National Institutes of Health.   If you have additional trial information please post it to our website or let us know by email.

BC ECPR Trial for Out-of-Hospital Cardiac Arrest

Condition:   Heart Arrest
Intervention:   Procedure: ECPR Protocol
Sponsors:   University of British Columbia;   Provincial Health Services Authority;   Physio-Control;   Providence HealthCare
Recruiting - verified August 2016

Amyotrophic Lateral Sclerosis and the Innate Immune System

Conditions:   Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:  
Sponsors:   Rigshospitalet, Denmark;   Roskilde County Hospital;   Bispebjerg Hospital;   Aarhus University Hospital;   Odense University Hospital
Recruiting - verified August 2016

Omental Islet Transplant

Condition:   Type 1 Diabetes
Interventions:   Procedure: Omental Islet transplant;   Drug: Anti-Thymocyte Globulin;   Drug: Mycophenolate mofetil;   Drug: Tacrolimus;   Drug: Etanercept;   Drug: Sirolimus
Sponsor:   University of Alberta
Recruiting - verified June 2016

Islet Transplant Alone in OMENtum

Conditions:   Islets of Langerhans Transplantation;   Diabetes Mellitus, Type 1
Intervention:   Biological: Biological: Islet transplantation
Sponsor:   Piemonti Lorenzo
Recruiting - verified June 2016

Deep Phenotyping in Patients With ALS

Conditions:   ALS;   Motor Neuron Disease
Intervention:  
Sponsors:   Barrow Neurological Institute;   ALS Association
Recruiting - verified February 2017

Genomic Translation for ALS Care

Condition:   ALS
Intervention:  
Sponsors:   Columbia University;   ALS Association;   Biogen
Recruiting - verified October 2016

Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants

Condition:   Healthy
Interventions:   Drug: Formulation A (ALS-008176);   Drug: Formulation B (ALS-008176);   Drug: Formulation C (ALS-008176);   Drug: Formulation D (ALS-008176);   Drug: Formulation E (ALS-008176);   Drug: Formulation F (ALS-008176);   Drug: Formulation G1 (ALS-008176);   Drug: Formulation G2 (ALS-008176);   Drug: Formulation G3 (ALS-008176);   Drug: Formulation H1 (ALS-008176);   Drug: Formulation H2 (ALS-008176);   Drug: Formulation H3 (ALS-008176)
Sponsor:   Janssen Research & Development, LLC

Pages